Skip to content

13F-HR filed by Prosight Management, LP

Prosight Management, LP filed this 13F-HR for the quarter ended 2019-12-31, filed 2020-02-14, with 38 holding rows worth $227,749,000.

Accession
0001420506-20-000263
Filed
2020-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2019

A holdings report, 38 entries on the cover page, a total value of $227,749,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $227,749,000 with VALUE read as thousands by filing date, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock130,000$19,458,000thousands by filing date
UNIQURE NVN90064101SHS237,500$17,019,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW328,129$14,904,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock1,036,000$14,245,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock161,195$14,198,000thousands by filing date
REATA PHARMACEUTICALS INC75615P103CL A62,900$12,859,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM388,600$10,756,000thousands by filing date
AC IMMUNE SAH00263105SHS1,242,843$10,589,000thousands by filing date
MEIRAGTX HOLDINGS PLCG59665102COMMON STOCK517,844$10,367,000thousands by filing date
ARQULE INC04269E107COM450,326$8,989,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock142,800$8,978,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM1,428,277$8,298,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM92,737$7,841,000thousands by filing date
UROGEN PHARMA LTDM96088105COMMON STOCK217,686$7,264,000thousands by filing date
ARENA PHARMACEUTICALS INC040047907CALL142,400$6,468,000thousands by filing datecall
ALBIREO PHARMA INC01345P106COMMON STOCK247,178$6,283,000thousands by filing date
ENVISTA HOLDINGS CORPORATION29415F104COM165,000$4,891,000thousands by filing date
PERSONALIS INC71535D106COMMON STOCK406,673$4,433,000thousands by filing date
ANAPTYSBIO INC032724106COM234,823$3,816,000thousands by filing date
IMMUNOVANT INC45258J102COM224,702$3,566,000thousands by filing date
ORGANOGENESIS HOLDINGS INC68621F102COMMON STOCK617,836$2,972,000thousands by filing date
EVOLUS INC30052C107COM236,939$2,884,000thousands by filing date
CATALYST BIOSCIENCES INC14888D208COM391,894$2,669,000thousands by filing date
STRONGBRIDGE BIOPHARMA PLCG85347105SHS USD1,258,224$2,630,000thousands by filing date
R1 RCM INC749397105COM200,000$2,596,000thousands by filing date
EVOLENT HEALTH INC CL A30050B101Stock279,390$2,528,000thousands by filing date
Cigna Corporation125523100COM11,293$2,309,000thousands by filing date
MOLECULAR TEMPLATES INC608550109COM160,883$2,250,000thousands by filing date
CUE BIOPHARMA INC22978P106COM137,628$2,185,000thousands by filing date
ALLAKOS INC01671P950PUT20,700$1,974,000thousands by filing dateput
PARATEK PHARMACEUTICALS INC699374302Equity450,000$1,814,000thousands by filing date
TRINET GROUP INC COM896288107Stock28,104$1,591,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM320,000$1,283,000thousands by filing date
TELIGENT INC NEW87960W104COM1,484,527$632,000thousands by filing date
AXSOME THERAPEUTICS INC.05464T954PUT6,000$620,000thousands by filing dateput
Milestone Pharmaceuticals Inc59935V107COM38,481$616,000thousands by filing date
Bristol-Myers Squibb Company110122108COM8,100$520,000thousands by filing date
APOLLO ENDOSURGERY INC03767D108COM159,336$454,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-20-000263this filing2020-02-14acceptance time not in the bulk data set